Polyglutamine domains are substrates of tissue transglutaminase: Does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 431-434

  Cooper, Arthur J L ^a,c   Sheu, Kwan Fu Rex ^a   Burke, James R ^b   Onodera, Osamu ^b   Strittmatter, Warren J ^b   Roses, Allen D ^b   Blass, John P ^a  

^a Department of Obstetrics Gynecology   (United States)

^b DUKE UNIVERSITY   (United States)

^c BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

CAG expansions; CAG repeats; Huntington's disease; Neurodegenerative diseases; Poly Q domains; Tissue transglutaminase

Indexed keywords

GLUTAMINE; GLUTATHIONE TRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REPETITIVE DNA;

ANIMAL TISSUE; ARTICLE; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME SUBSTRATE; GUINEA PIG; HUNTINGTON CHOREA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030906890     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010431.x     Document Type: Article

References (22)

1. Burke J. R., Enghild J. J., Martin M. E., Jou Y.-S., Myers R. M., Roses A. D., Vance J. M., and Strittmatter W. J. (1996) Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med. 2, 347-350.
2. Cooper A. J. L., Sheu K.-F. R., Burke J. R., Onodera O., Strittmatter W. J., Roses A. D., and Blass J. P. (1997) Poly-Q inhibition of α-ketoglutarate-and pyruvate dehydrogenase activities in E. coli. Are neurodegenerative diseases associated with poly-Q expansions due in part to an energy deficit? Age (in press).
3. Facchiano F. and Luini A. (1992) Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity. J. Biol. Chem. 267, 13267-13271.
4. Facchiano F., Benfenati F., Valtorta F., and Luini A. (1993) Covalent modification of synapsin I by tetanus toxin-activated transglutaminase. J. Biol. Chem. 268, 4588-4595.
5. Fesus L., Davies P. J. A., and Piacentini M. (1991) Apoptosis: molecular mechanisms in programmed cell death. Eur. J. Cell Biol. 56, 170-177.
6. Folk J. E. and Cole P. W. (1966) Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim. Biophys. Acta 122, 244-264.
7. Green H. (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74, 955-956.
8. Grootjans J. J., Groenen P. J. T. A., and de Jong W. W. (1995) Substrate requirements for transglutaminases. Influence of the amino acid residue preceding the amine donor lysine in a native protein. J. Biol. Chem. 270, 22855-22858.
9. Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S., and Kakizuka A. (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death. Nat. Genet. 13, 196-202.
10. Imbert G., Saudou I., Yvert G., Devys D., Trottier Y., Gamier J. M., Weber C., Mandel J.-L., Cancel G., Abbas N., Durr A., Didier-jean O., Stevanin G., Agid Y., and Brice A. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 14, 285-291.
11. Kahlem P., Terré C., Green H., and Djian P. (1996) Peptides containing glutamine repeats are substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA 93, 14580-14585.
12. Koshy B., Matilla T., Burright E. N., Merry D. E., Fischbeck K. H., Orr H. T., and Zoghbi H. Y. (1996) Spinocerebellar ataxia type-1 and spinocerebellar muscular atrophy gene products interact with glyceraldehyde-phosphate dehydrogenase. Hum. Mol. Genet. 5, 1311-1318.
13. Linblad K., Savontaus M. L., Stevanin G., Holmberg M., Digre K., Zander C., Ehrsson H., David G., Benomar A., Nikoskelainen E., Trottier Y., Holmgren G., Ptacek L. J., Antinnen A., Brice A., and Schalling M. (1996) An expanded CAG repeat sequence in spinocerebellar ataxia type 7. Genome Res. 6, 965-971.
14. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
15. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
16. Ohashi H., Itoh Y., Birckbichler P. J., and Takeuchi Y. (1995) Purification and characterization of rat brain transglutaminase. J. Biochem. (Tokyo) 118, 1271-1278.
17. Onodera O., Roses A., Tsuji S., Vance J. M., Strittmatter W. J., and Burke J. R. (1996) Toxicity of expanded polyglutamine-domain proteins in Escherichia coli. FEBS Lett. 399, 135-139.
18. Pastuszko A., Wilson D. F., and Erecińska M. (1986) A role of transglutaminase in neurotransmitter release by rat brain synaptosomes. J. Neurochem. 46, 499-508.
19. Reichelt K. L. and Poulsen E. (1992) γ-Glutamylaminotransferase and transglutaminase in subcellular fractions of rat cortex and in cultured astrocytes. J. Neurochem. 59, 500-504.
20. Seiler N. and Deckard K. (1976) Association of putrescine, spermidine and GABA with structural elements of brain cells. Neurochem. Res. 1, 469-499.
21. Sorbi S., Bird E., and Blass J. P. (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72-78.
22. Stott K., Blackburn J. M., Butler P. J. G., and Perutz M. (1995) Incorporation of glutamine repeats makes protein oligomerize. Proc. Natl. Acad. Sci. USA 92, 6509-6513.